I31-ROR Trademark

Trademark Overview

On Thursday, January 27, 2022, a trademark application was filed for I31-ROR with the United States Patent and Trademark Office. The USPTO has given the I31-ROR trademark a serial number of 97241359. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2024. This trademark is owned by Castle Biosciences Incorporated. The I31-ROR trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical testing for diagnostic or treatment purposes in the field of integrating the pathology of a tumor, mycotic activity and thickness with a gene expression test using artificial intelligence; Medical testing for diagnostic or treatment purposes
i31-ror

General Information

Serial Number97241359
Word MarkI31-ROR
Filing DateThursday, January 27, 2022
Status700 - REGISTERED
Status DateTuesday, October 1, 2024
Registration Number7523888
Registration DateTuesday, October 1, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 20, 2022

Trademark Statements

Pseudo MarkI THIRTY ONE RISK OF RECURRENCE; I THREE ONE RISK OF RECURRENCE
Goods and ServicesMedical testing for diagnostic or treatment purposes in the field of integrating the pathology of a tumor, mycotic activity and thickness with a gene expression test using artificial intelligence; Medical testing for diagnostic or treatment purposes

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, February 1, 2022
Primary Code044
First Use Anywhere DateWednesday, July 19, 2023
First Use In Commerce DateWednesday, July 19, 2023

Trademark Owner History

Party NameCastle Biosciences Incorporated
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressFriendswood, TX 77546
Party NameCastle Biosciences Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFriendswood, TX 77546
Party NameCastle Biosciences Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFriendswood, TX 77546

Trademark Events

Event DateEvent Description
Monday, January 31, 2022NEW APPLICATION ENTERED
Tuesday, February 1, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 13, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 13, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 13, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022ASSIGNED TO EXAMINER
Tuesday, November 15, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 20, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 20, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, August 7, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 7, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 7, 2023SOU EXTENSION 1 FILED
Monday, August 7, 2023USE AMENDMENT FILED
Monday, August 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 14, 2023SOU EXTENSION 1 GRANTED
Monday, August 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, August 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 29, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 6, 2023SU - NON-FINAL ACTION - WRITTEN
Wednesday, September 6, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 27, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Monday, November 27, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Thursday, February 8, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 29, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 29, 2024ASSIGNED TO LIE
Tuesday, August 27, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 27, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, October 1, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

purposes medical treatment diagnostic testing test expression intelligence gene artificial